VR Solace for Pain and Anxiety Using Survey and Biodata

Omer Liran

Status and phase

Not yet enrolling

Phase 2

Conditions

Chronic Pain

Treatments

Device: VR Solace

Study type

Interventional

Funder types

Other

Identifiers

NCT05468086

STUDY00002144

Details and patient eligibility

About

The purpose of this study is to assess the therapeutic response to VR Solace in patients with chronic pain and anxiety using real-time clinical and survey data. Regression analysis of demographic characteristics, lab and survey data will be conducted to better understand the efficacy of VR Solace in treating chronic pain and anxiety. The investigator also aims to explore the possible association between the patient-reported changes in pain or anxiety levels with real-time physiological changes observed during VR Solace use.

Enrollment

34 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age 18+
Endorsing pain/anxiety with objective measurement of 3 or greater on 10-point scale on validated survey
Diagnosis with chronic pain/anxiety

Exclusion criteria

Exclusion of patients that are followed by CL Psychiatry team at Cedars-Sinai Medical Center to avoid overlap with another ongoing VR study
No active diagnosis of medical conditions that may cause physiological variations in vital signs (i.e. sepsis, cardiogenic shock/arrhythmia)
No active diagnosis of seizures, migraines, severe nausea, severe propensity for motion sickness, or facial/head deformities that would allow for comfortable placement of headset
Exclusions of patient currently taking beta blockers
Unable to communicate/read English for survey items
Unable to use VR independently - patients will be expected to maneuver through questions/steps of the VR system during the session